Omnicell Files 8-K for Regulatory Disclosure
Ticker: OMCL · Form: 8-K · Filed: Dec 8, 2025 · CIK: 926326
| Field | Detail |
|---|---|
| Company | Omnicell, Inc. (OMCL) |
| Form Type | 8-K |
| Filed Date | Dec 8, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, disclosure
Related Tickers: OMCL
TL;DR
Omnicell filed a routine 8-K on 12/8/25 for disclosures, no major news.
AI Summary
Omnicell, Inc. filed an 8-K on December 8, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Omnicell is adhering to its reporting obligations with the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for regulatory disclosures and does not appear to contain any new material information that would immediately impact risk.
Key Players & Entities
- OMNICELL, INC. (company) — Registrant
- December 8, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is December 8, 2025.
What is Omnicell, Inc.'s state of incorporation?
Omnicell, Inc. is incorporated in Delaware.
What is Omnicell, Inc.'s IRS Employer Identification Number?
Omnicell, Inc.'s IRS Employer Identification Number is 94-3166458.
What is the principal executive office address for Omnicell, Inc.?
The principal executive office address for Omnicell, Inc. is 4220 North Freeway, Fort Worth, TX 76137.
Filing Stats: 541 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-12-08 08:18:56
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value OMCL NASDAQ Global Select M
Filing Documents
- tm2532894d1_8k.htm (8-K) — 24KB
- tm2532894d1_ex99-1.htm (EX-99.1) — 19KB
- tm2532894d1_ex99-1img01.jpg (GRAPHIC) — 5KB
- 0001104659-25-119083.txt ( ) — 217KB
- omcl-20251208.xsd (EX-101.SCH) — 3KB
- omcl-20251208_lab.xml (EX-101.LAB) — 33KB
- omcl-20251208_pre.xml (EX-101.PRE) — 22KB
- tm2532894d1_8k_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On December 8, 2025, Omnicell, Inc. (the "Company") issued a press release announcing the launch of Omnicell Titan XT, its next generation, automated dispensing system designed to empower autonomous medication management. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto are being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any Company filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description of Document 99.1 Press release entitled "Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management" dated December 8, 2025 104 Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. OMNICELL, INC. Date: December 8, 2025 /s/ H. Baird Radford, III H. Baird Radford, III Executive Vice President and Chief Financial Officer